SN
Sadasivan Nair Athira
About Sadasivan Nair Athira
Data last updated:
Sadasivan Nair Athira is a Director at Aldic Pharmaceuticals Private Limited (since 2024) and Director at Bonnbio Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Aldic Pharmaceuticals Private Limited at ₹32.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aldic Pharmaceuticals Private Limited U51397KL2006PTC020012 | Director | 20 Jan 2024 | 2006 | ₹32.5 Lakh (FY 2025) | Active |
| Bonnbio Pharmaceuticals Private Limited U46596KL2023PTC083133 | Director | 23 Aug 2023 | 2023 | Active |
Board colleagues of Sadasivan Nair Athira
| Name | DIN | Company | Designation |
|---|---|---|---|
| Binu Kumar Sasi | 00767460 | Aldic Pharmaceuticals Private Limited , Bonnbio Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sadasivan Nair Athira
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sadasivan Nair Athira
Sadasivan Nair Athira currently holds 2 directorships: Aldic Pharmaceuticals Private Limited (Director, since 20 Jan 2024, revenue ₹32.5 Lakh (FY 2025)); Bonnbio Pharmaceuticals Private Limited (Director, since 23 Aug 2023).
Sadasivan Nair Athira was first appointed on 23 Aug 2023 as Director at Bonnbio Pharmaceuticals Private Limited. The most recent appointment on record is 20 Jan 2024 at Aldic Pharmaceuticals Private Limited.
The current boards of Sadasivan Nair Athira's companies include Binu Kumar Sasi (Aldic Pharmaceuticals Private Limited).